Company / Free Cash Flow
TG Therapeutics, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$25.0M
FY2025
5-year range
-$296.0M / -$25.0M
FY2021-FY2025
Trend
+38.4%
vs FY2024
Sector context
#73 of 194
Health Care
What the data says
At -$25M, TG Therapeutics, Inc.'s free cash flow ranks #73 of 194 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from -$296M in FY2021 to -$25M in FY2025.
Based on SEC 10-K filings.
-$25M in FY2025.
Improved from -$31M to -$25M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#73 of 194 in Health CareTop 38% of 194This company -$25.0M Sector average $470.6M
▼
-105.3% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 38.4% year-over-year.
- Ranks #73 out of 194 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$25.0M | +38.4% |
| FY2024 | -$40.6M | -29.1% |
| FY2023 | -$31.4M | +82.2% |
| FY2022 | -$176.2M | +40.5% |
| FY2021 | -$296.0M | -37.8% |
| FY2020 | -$214.9M | -129.2% |
| FY2019 | -$93.8M | +27.3% |
| FY2018 | -$129.0M | -37.6% |
| FY2017 | -$93.8M | -51.4% |
| FY2016 | -$61.9M | -38.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026